@article {Zouhair:2010:0929-8673:2492,
	author = "Zouhair, A. and Ozsahin, M. and Schaffer, M. and Albrecht, S. and Camus, F. and Jichlinski, P. and Mirimanoff, R.-O. and Bischof Delaloye, A. and Meuwly, J.-Y. and Prior, J.O.",
	title = "Positron Emission Tomography and Computer Tomography (PET/CT) in Prostate, Bladder, and Testicular Cancers",
	journal = "Current Medicinal Chemistry",
	volume = "17",
	number = "23",
	year = "2010",
	abstract = "Positron emission computed tomography (PET) is a functional, noninvasive method for imaging regional metabolic processes that is nowadays most often combined to morphological imaging with computed tomography (CT). Its use is based on the well-founded assumption that metabolic changes occur earlier in tumors than morphologic changes, adding another dimension to imaging. This article will review the established and investigational indications and radiopharmaceuticals for PET/CT imaging for prostate cancer, bladder cancer and testicular cancer, before presenting upcoming applications in radiation therapy.",
	pages = "2492-2502",
	url = "http://www.ingentaconnect.com/content/ben/cmc/2010/00000017/00000023/art00004",
	doi = "doi:10.2174/092986710791556014",
	keyword = "Prostate cancer, bladder cancer, testicular cancer, positron emission tomography, F-18-fluorodeoxyglucose"
}